e-learning
resources
ERS Research Seminars
2006
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Newborn screening in Europe
K. Southern (Liverpool, United Kingdom)
Source:
Research Seminar 2006 - Preventing respiratory sequelae in children diagnosed with cystic fibrosis by newborn screening
Number:
1
Disease area:
Paediatric lung diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
K. Southern (Liverpool, United Kingdom). Newborn screening in Europe. Research Seminar 2006 - Preventing respiratory sequelae in children diagnosed with cystic fibrosis by newborn screening
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Cystic fibrosis and intestinal organoids
Clinics of Cystic Fibrosis Patients with Unusual Bacteria Isolated fromRespiratory Cultures
Novel therapeutics for cystic fibrosis
Related content which might interest you:
Should the D1152H variant be included in cystic fibrosis newborn screening programmes?
Source: Virtual Congress 2020 – Cystic fibrosis
Year: 2020
Newborn screening for cystic fibrosis - lessons from national programmes in Europe
Source: International Congress 2018 – PG10 Cystic fibrosis: Basic defects and clinical problems in children
Year: 2018
Newborn screening and carrier screening for cystic fibrosis: alternative or complementary?
Source: Eur Respir J 2014; 43: 20-23
Year: 2004
Cystic fibrosis diagnosis in adulthood as a result of study of relatives within the newborn screening programme
Source: International Congress 2015 – Cystic fibrosis: assessment and treatment
Year: 2015
1-PRO "Newborn screening for cystic fibrosis should be added to routine newborn screening programmes"
Source: Annual Congress 2010 - Pro/Con debates: 1. To screen or not to screen for cystic fibrosis: is it still the question, 2. Specific immunotherapy for asthma
Year: 2010
Newborn screening for cystic fibrosis in Spain
Source: International Congress 2016 – Cystic fibrosis: various aspects
Year: 2016
Stable lung function is maintained over 2 years in newborn screened (NBS) CF infants
Source: Annual Congress 2013 –Cystic fibrosis: lung function and change of lung function in infants and children before and after treatment
Year: 2013
Cystic fibrosis newborn screening for R117H in England
Source: Virtual Congress 2020 – Cystic fibrosis
Year: 2020
Ventilation distribution is not influenced by structural lung disease in infants with cystic fibrosis (CF) diagnosed following newborn screening (NBS)
Source: Annual Congress 2009 - Cystic fibrosis: disease progression and novel therapies
Year: 2009
Within-subject variability of lung function in newborn screened (NBS) CF infants
Source: International Congress 2016 – Cystic fibrosis: inflammation, microbiology, management and monitoring
Year: 2016
Newborn cystic fibrosis (CF) screening: influence of data transformation and density estimation on newborn recall
Source: Eur Respir J 2007; 30: Suppl. 51, 30s
Year: 2007
Newborn screening for cystic fibrosis: opportunities and remaining challenges
Source: Eur Respir Monogr 2014; 64: 65-76
Year: 2014
Newborn screening for Cystic Fibrosis over 20 years and the identification of affected not detected infants.
Source: International Congress 2018 – Cystic fibrosis in paediatric patients: current research
Year: 2018
Cystic fibrosis newborn screening programme in central Catalonia area (Spain). What have we learnt 8 years later?
Source: Annual Congress 2008 - Cystic fibrosis: new mechanisms, monitoring and treatment tools
Year: 2008
Normal lung function in infants with cystic fibrosis shortly after birth
Source: Annual Congress 2013 –Cystic fibrosis: lung function and change of lung function in infants and children before and after treatment
Year: 2013
Longitudinal study of lung function in infants with cystic fibrosis diagnosed by newborn screening: Preliminary results
Source: Annual Congress 2010 - Advances in lung function from infancy to adolescence
Year: 2010
Is lung function diminished by 3 months of age in infants with cystic fibrosis (CF) diagnosed by newborn screening (NBS)?
Source: Annual Congress 2010 - Functional assessment of paediatric lung disease
Year: 2010
Early diagnosis from newborn screening maximises survival in severe cystic fibrosis
Source: ERJ Open Res, 4 (2) 00109-2017; 10.1183/23120541.00109-2017
Year: 2018
Cystic fibrosis
Source: ISSN=ISSN 1025-448x, ISBN=ISBN 1-904097-50-2, page=234
Year: 2006
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept